FRONTIER4 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

96 results for “FRONTIER4”

Trials

View all 14 →

Frontier Registry II Bifurcation Stent System Registry

First posted Feb 3, 2006

HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry

2,000 participants · First posted May 22, 2024

Not yet recruiting

Validation Study of Frontier X Plus (FX+) Device

125 participants · First posted Jun 24, 2024

Drugs

Teriparatide biosimilar(Frontier Biotechnologies)

KRAS G12C inhibitors (Frontier Medicines)

MYBPC3-targeting gene therapy (Frontera)

Organizations

Frontier Biotechnologies Inc.

China

FRONTIER MEDICINES CORPORATION

United States

Frontier Biotechnologies Inc.

News

View all 70 →

Novo Nordisk Presents Promising Data on Sickle Cell Disease and Hemophilia Treatments at ASH 2024

Novo Nordisk's Mim8 Shows Promise in Phase III Pediatric Hemophilia A Trial

Novo Nordisk's Mim8 Shows Safe Direct Switch from Emicizumab in Phase 3b Hemophilia A Trial

Page 1 of 10